TGA
Concerns over Champix
Potential contamination of varenicline medicines being investigated by the TGA as batch recall begins The Therapeutic Goods Administraion (TGA) says it is investigating potential contamination of varenicline medicines with the …
Struggling for supply
Shortage notice issued for multiple presentations of arthritis treatment The Therapeutic Goods Administration (TGA) has issued a warning regarding shortages of multiple presentations of tocilizumab (Actemra). Roche, the sponsor of …
Benzene recall alert
The recall of a spray sunscreen shows Australian regulations work, says one expert The TGA has announced that Johnson & Johnson Pacific is recalling all batches of Neutrogena Ultra Sheer …
$11m unlawful advertising penalty sets a record
A supplier of unapproved sports supplements has been told to pay $11 million, as the TGA points out their potential to damage health The Federal Court of Australia has ordered …
Restricted representations
The TGA has handed down more than $23K in fines relating to unlawful advertising of medicinal cannabis to treat cancer, and of homeopathy for COVID-19 The Therapeutic Goods Administration made …
Four additional AZ blood clotting events: TGA
Two fatalities reported, however total thrombosis numbers down from previous week There were a total of four blood clotting events apparently connected to the Astra Zeneca vaccine rollout recorded over …
The week in review
Developing news around pharmacy’s role in the COVID-19 vaccination program dominated the news cycle during the week All eligible community pharmacies across Australia were finally the green light to join …
Nangs decision delayed
TGA holds off publicising decision on the rescheduling of nitrous oxide Publication of the TGA scheduling committee’s interim decision and invitation to comment on a rescheduling proposal for nitrous oxide …
Out of public view
Medicines scheduling committee knocks back attempts to allow advertising for a number of Pharmacist Only medications The Therapeutic Goods Administration has rejected proposed amendments to current medicine schedules that would …
Recall underway
Consumer concerns over difficulties contacting manufacturer after Philips initiates a recall of some of its CPAP and other devices The Therapeutic Goods Administration has issued updated advice about the ongoing …
Arthritis drug shortage looms
TGA working with wholesalers to restrict available Actemra stock to community pharmacies and hospitals as stocks dwindle Australia faces a shortage of arthritis drug Actemra (tocilizumab) following recommendation by the …
Communicating about COVID
TGA reveals how health professionals can, and cannot, communicate with patients about their COVID-19 vaccination services The Therapeutic Goods Administration has released guidance explaining how health professionals can lawfully provide …